Windsor Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Windsor Capital Management's AMGN Position: Q2 2026 in Review
Windsor Capital Management reduced its Amgen (AMGN) stake by 11% in Q2 2026, selling an estimated $141K and leaving 3,307 shares worth $1.2M. The position accounts for 0.31% of the portfolio, ranked #50.
Windsor Capital Management first reported a position in AMGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.31M in Q1 2026. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Windsor Capital Management held 3,307 shares of Amgen worth $1.2M as of Q2 2026.
- Windsor Capital Management sold 413 Amgen shares in Q2 2026, an estimated $141K.
- Amgen made up 0.31% of Windsor Capital Management's portfolio in Q2 2026, its #50 holding.
- Windsor Capital Management first reported a position in Amgen in Q2 2024 and has held it in 9 quarters since.
- Windsor Capital Management's Amgen position peaked at $1.31M in Q1 2026.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Windsor Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.